Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide is a dual-agonist peptide that targets both GLP-1 and GIP receptors with engineered affinity ratios
When tirzepatide is administered, it acts on the GLP-1 and GIP receptors, which are critical in regulating appetite, insulin secretion, and blood sugar levels
The 5-Day Half-Life: This medication is designed to last a long time
These results help your provider identify factors that may affect weight and determine which options are appropriate to consider
APPENDIX: GLP-1 and Addiction Human Trials in Progress Please be in touch if you are aware of other trials that are not listed below
References DailyMed MOUNJARO- tirzepatide injection, solution
US$ 20.54
US$ 28.38
US$ 24.08
US$ 22.10
US$ 23.91
